Stamford, CT -- (SBWIRE) -- 01/17/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Intel Corporation (NASDAQ:INTC), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), E Commerce China Dangdang Inc (ADR) (NYSE:DANG), Cell Therapeutics Inc (NASDAQ:CTIC)
Intel Corporation (NASDAQ:INTC) opened the session at $26.64, trading in a range of $26.33 - $26.74. The stock showed a negative performance of -0.49% in the last trading session from its previous close of $25.16 and closed at $26.54. The stock traded on a volume of 49.52 million shares and the average volume of the stock remained 31.80 million shares. Intel Corporation designs and manufactures integrated digital technology platforms. A platform consists of a microprocessor and chipset. The Company’s platforms are used in a range of applications, such as personal computers (PCs) (including Ultrabook systems), data centers, tablets, smartphones, automobiles, automated factory systems and medical devices.
Has INTC Found The Bottom and Ready To Move Up? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traded 12.48 million shares in the last business day while the average volume of the stock remained 4.79 million shares. The stock showed a positive movement of +5.61% to end at $7.72. The 52 week range of the stock remained $4.5 - $11.00. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
For How Long ARNA s Gloss will Attract Investors? Find out via this report
E Commerce China Dangdang Inc (ADR) (NYSE:DANG) reported 3.61 million shares were exchanged during the last trade, while the average volume is about 1.95 million shares. The stock escalated +5.21% and finished the day at $11.31. The beta of the stock is recorded at 4.88. E-Commerce China Dangdang Inc. (Dangdang) is a holding company. It is a business-to-consumer (B2C), e-commerce Company in the People’s Republic of China. As of September 30, 2010, it offered approximately 590,000 book titles on its Website, including more than 570,000 Chinese language titles.
For How Long DANG’s Gloss will Attract Investors? Find out via this report
Cell Therapeutics Inc (NASDAQ:CTIC) shares rose, +4.92 percent from its previous close of $3.05 to close at $3.20. Traded with volume of 5.16 million shares in the prior session and the average volume of the stock remained 3.88 million shares. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
Why Should Investors Buy CTIC After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)